72 related articles for article (PubMed ID: 9037441)
1. Synthesis and antihyperlipaemic activity of some novel N-cyanovinylformamidines.
Shishoo CJ; Chhabria MT; Gandhi TP; Bangaru RA
Arzneimittelforschung; 1997 Jan; 47(1):35-8. PubMed ID: 9037441
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antihyperlipaemic activity of some 2-aminomethyl-3-aryl-5,6,7,8-tetrahydrobenzo(b)/5,6-dimethylthieno++ +(2,3- d) -pyrimidin-4-ones.
Gadad AK; Kapsi SG; Anegundi RI; Pattan SR; Mahajanshetti CS; Shishoo CJ
Arzneimittelforschung; 1996 Oct; 46(10):981-5. PubMed ID: 8931892
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological study of antihyperlipaemic activity of 2-substituted thieno(2,3-d)pyrimidin-4(3H)-ones.
Shishoo CJ; Devani MB; Bhadti VS; Jain KS; Rathod IS; Goyal RK; Gandhi TP; Patel RB; Naik SR
Arzneimittelforschung; 1990 May; 40(5):567-72. PubMed ID: 2383297
[TBL] [Abstract][Full Text] [Related]
4. N-arylpiperazinyl derivatives of 2,3-dihydrobenzoxazin[1,4]-3-ones synthesis and normolipemic activity.
Depreux P; Moussavi Z; Lesieur D; Sauzieres J
Farmaco; 1993 Aug; 48(8):1079-89. PubMed ID: 8216670
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and hypolipidemic activity of novel 2-(m-tolyloxy) isobutyric acid derivatives.
Idrees GA; Abuo-Rahma Gel-D; Aly OM; Radwan MF
Eur J Med Chem; 2009 Jun; 44(6):2679-84. PubMed ID: 19121550
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs.
van Vlijmen BJ; Pearce NJ; Bergö M; Staels B; Yates JW; Gribble AD; Bond BC; Hofker MH; Havekes LM; Groot PH
Arzneimittelforschung; 1998 Apr; 48(4):396-402. PubMed ID: 9608883
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and hypolipidemic activity of novel 2-(naphthalen-2-yloxy)propionic acid derivatives as desmethyl fibrate analogs.
Idrees GA; Aly OM; Abuo-Rahma Gel-D; Radwan MF
Eur J Med Chem; 2009 Oct; 44(10):3973-80. PubMed ID: 19450906
[TBL] [Abstract][Full Text] [Related]
8. Hypolipemic activity of clofibrate-related compounds.
Metz G; Specker M
Arzneimittelforschung; 1975 Nov; 25(11):1686-92. PubMed ID: 1243074
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and hypolipidemic evaluation of beta-alkylaminopropiophenone and beta-alkylaminopropio-2'-naphthone derivatives in rodents.
Huang Y; Hall IH
Pharmazie; 1996 Apr; 51(4):199-206. PubMed ID: 8628737
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and hypolipidemic activities of novel 2-[4-[diethoxyphosphoryl)methyl]phenyl]quinazolines and 4(3H)-quinazolinones.
Kurogi Y; Inoue Y; Tsutsumi K; Nakamura S; Nagao K; Yoshitsugu H; Tsuda Y
J Med Chem; 1996 Mar; 39(7):1433-7. PubMed ID: 8691473
[TBL] [Abstract][Full Text] [Related]
11. Hypolipidemic activity of some derivatives of 6H-dibenzo[b,d]pyran.
Banzatti C; Branzoli U; Lovisolo PP; Melloni P; Orsini G; Salvadori P
Arzneimittelforschung; 1984; 34(8):864-9. PubMed ID: 6541922
[TBL] [Abstract][Full Text] [Related]
12. Hypolipidemic activity of 1-acyl- and 1,2-diacyl-3,5-pyrazolidinediones.
Izydore RA; Bernal-Ramirez JA; Okwisa WA; Yarborough LV; Wong OT; Hall IH
Pharmazie; 1993 Feb; 48(2):111-7. PubMed ID: 8475157
[TBL] [Abstract][Full Text] [Related]
13. Novel antidiabetic and hypolipidemic agents. 3. Benzofuran-containing thiazolidinediones.
Reddy KA; Lohray BB; Bhushan V; Bajji AC; Reddy KV; Reddy PR; Krishna TH; Rao IN; Jajoo HK; Rao NV; Chakrabarti R; Dileepkumar T; Rajagopalan R
J Med Chem; 1999 Jun; 42(11):1927-40. PubMed ID: 10354401
[TBL] [Abstract][Full Text] [Related]
14. Lipid lowering activity of ethanolic extract of leaves of Aegle marmelos (Linn.) in hyperlipidaemic models of Wistar albino rats.
Vijaya C; Ramanathan M; Suresh B
Indian J Exp Biol; 2009 Mar; 47(3):182-5. PubMed ID: 19405383
[TBL] [Abstract][Full Text] [Related]
15. Post-prandial effects of gemfibrozil vs simvastatin in hypercholesterolemic subjects with borderline hypertriglyceridemia.
Vigna GB; Donega P; Passaro A; Zanca R; Cattin L; Fonda M; Pauciullo P; Marotta G; Fellin R; Gasparrini S; Piliego T
Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):234-43. PubMed ID: 10656170
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of the antihyperlipaemic activity and pharmacokinetics of 2-chloromethyl-5,6,7,8-tetrahydrobenzo(b)thieno[2,3-d]pyrimidin-4(3H)-o ne.
Shishoo CJ; Gandhi TR; Rathod IS; Jain KS; Goyal RK
Arzneimittelforschung; 1997 Oct; 47(10):1125-9. PubMed ID: 9368706
[TBL] [Abstract][Full Text] [Related]
17. Novel 2,3-dihydrobenzofuran-2-carboxylic acids: highly potent and subtype-selective PPARalpha agonists with potent hypolipidemic activity.
Shi GQ; Dropinski JF; Zhang Y; Santini C; Sahoo SP; Berger JP; Macnaul KL; Zhou G; Agrawal A; Alvaro R; Cai TQ; Hernandez M; Wright SD; Moller DE; Heck JV; Meinke PT
J Med Chem; 2005 Aug; 48(17):5589-99. PubMed ID: 16107159
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the hypolipaemic activity of etofylline clofibrate, a new ester of etofylline and clofibric acid, and comparison with effects of known hypolipaemic agents.
Davies JE; Kellett DN
Arzneimittelforschung; 1980; 30(11b):2035-7. PubMed ID: 7194055
[TBL] [Abstract][Full Text] [Related]
19. Gemfibrozil increases paraoxonase activity in type 2 diabetic patients. A new hypothesis of the beneficial action of fibrates?
Balogh Z; Seres I; Harangi M; Kovács P; Kakuk G; Paragh G
Diabetes Metab; 2001 Nov; 27(5 Pt 1):604-10. PubMed ID: 11694861
[TBL] [Abstract][Full Text] [Related]
20. Studies on antihyperlipidemic agents. I. Synthesis and hypolipidemic activities of phenoxyphenyl alkanoic acid derivatives.
Kawamatsu Y; Saraie T; Imamiya E; Nishikawa K; Hamuro Y
Arzneimittelforschung; 1980; 30(3):454-9. PubMed ID: 7387754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]